Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Synlogic Inc (SYBX)

Synlogic Inc (SYBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement Business Wire - Wed Jul 29, 6:00AM CDT

Combined company to operate as Caldera Therapeutics, developing CLD-423, a potential first-in-class TL1A x IL-23p19 bispecific antibody for inflammatory bowel disease and other immune-mediated diseases...

SYBX : 1.2000 (+4.35%)
Synlogic Reports Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 2024

SYBX : 1.2000 (+4.35%)
Synlogic Flat on Q1 Numbers Baystreet - Tue May 14, 2024

Synlogic, Inc. (NASDAQ: SYBX) waned Tuesday, after reporting financial results for the first quarter ...

SYBX : 1.2000 (+4.35%)
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks PR Newswire - Thu Aug 11, 2022

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...

DNA : 8.09 (unch)
SYBX : 1.2000 (+4.35%)
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update Globe Newswire - Thu Aug 11, 2022

– Three clinical data readouts across three programs expected in H2 2022 – – PKU Phase 3 readiness activities underway for planned start in H1 2023 – – ...

SYBX : 1.2000 (+4.35%)

Barchart Exclusives

Seagate Rallies on Strong Q4 Results and Guidance. What Does This Mean for STX Stock Here. Barchart - 25 minutes ago
Seagate recently reported a beat on both revenue and earnings, along with guidance that came in above estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.